Skip to main content
iwCLL 2025 Main banner
Final Program


iwCLL X / Twitter

Poster

1117 - The clinical significance of specific SF3B1 mutation variants in Chinese patients with chronic lymphocytic leukemia

    Primary Author / Presenter(s)

  • YM

    Yi Miao, MD

    Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

    • Co-Author(s)

  • CQ

    Chun Qiao, PhD

    Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
    Nanjing, China (People's Republic)

  • HJ

    Huimin Jin, Master of Medicine

    The First Affiliated Hospital of Nanjing Medical University

  • Lei Fan, MD

    the First Affiliated Hospital with Nanjing Medical University
    Nanjing, Jiangsu, China (People's Republic)

  • JL

    Jianyong Li, MD

    Chief of Hematology department
    Department of Hematology, Key Laboratory of Nanjing Medical University, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, China
    Nanjing, Jiangsu, China (People's Republic)